학술논문

Impact of hypertension diagnosis on morbidity and mortality: a retrospective cohort study in primary care.
Document Type
Article
Source
BMC Primary Care. 3/23/2023, Vol. 24 Issue 1, p1-9. 9p.
Subject
*KIDNEY disease risk factors
*HYPERTENSION
*CARDIOVASCULAR diseases risk factors
*CONFIDENCE intervals
*MORTALITY
*AGE distribution
*DISEASES
*RETROSPECTIVE studies
*PRIMARY health care
*RISK assessment
*KIDNEY diseases
*INDEPENDENT living
*DESCRIPTIVE statistics
*AGE factors in disease
*RESEARCH funding
*PROPORTIONAL hazards models
CARDIOVASCULAR disease related mortality
Language
ISSN
2731-4553
Abstract
Background: Hypertension is responsible for a huge burden of disease. The aim of this study was to evaluate the impact of newly diagnosed hypertension on the occurrence of kidney or cardiovascular events (K/CVEs) and on mortality among community dwellers. Methods: Retrospective cohort study, conducted from January, 2007, to December, 2018. All patients (age > 18) newly diagnosed with hypertension and no previous K/CVEs in 2007 and 2008, in the primary care centers of Madrid (Spain) (n = 71,770), were enrolled. The control group (n = 72,946) included patients without hypertension, matched by center, sex and age. The occurrence of kidney or CV events, including mortality from these causes and total mortality were evaluated using Cox regression and multistate models. Data were collected from three sources: personal data from administrative records, clinical data from medical records, and mortality data from regional and national databases. Results: The median follow-up was 138.61 months (IQR: 124.68–143.97 months). There were 32,896 K/CVEs (including 3,669 deaths from these causes) and 12,999 deaths from other causes. Adjusted for sex, smoking, diabetes and socioeconomic status, K/CVEs HR was 4.36 (95% CI: 3.80–5.00) for diagnoses before 45 years of age, 2.45(95% CI: 2.28- 2.63) for diagnosis between 45 to 54 years, and HR decreased to 1.86 (95% CI: 1.64–210) for diagnoses over age 85. Total mortality risk was only higher for hypertension diagnosed before 55 years of age (HR: 2.47, 95% CI: 1.90–3.19 for ages 18 to 44; and HR: 1.14, 95% CI: 1.02–1.28 for ages 45 to 54). Conclusion: The diagnosis of hypertension in the community environment, in patients without evidence of previous kidney or CV disease, is associated with a large increase in the risk of K/CVEs, but especially in individuals diagnosed before the age of 55. This diagnosis is only associated with an increase in kidney or cardiovascular mortality or overall mortality when it occurs before age 55. [ABSTRACT FROM AUTHOR]